949 related articles for article (PubMed ID: 17683790)
1. Involvement of dopamine (DA)/serotonin (5-HT)/sigma (sigma) receptor modulation in mediating the antidepressant action of ropinirole hydrochloride, a D2/D3 dopamine receptor agonist.
Dhir A; Kulkarni SK
Brain Res Bull; 2007 Sep; 74(1-3):58-65. PubMed ID: 17683790
[TBL] [Abstract][Full Text] [Related]
2. On the mechanism of antidepressant-like action of berberine chloride.
Kulkarni SK; Dhir A
Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
[TBL] [Abstract][Full Text] [Related]
3. Involvement of sigma-1 receptor modulation in the antidepressant action of venlafaxine.
Dhir A; Kulkarni SK
Neurosci Lett; 2007 Jun; 420(3):204-8. PubMed ID: 17532136
[TBL] [Abstract][Full Text] [Related]
4. Possible involvement of sigma-1 receptors in the anti-immobility action of bupropion, a dopamine reuptake inhibitor.
Dhir A; Kulkarni SK
Fundam Clin Pharmacol; 2008 Aug; 22(4):387-94. PubMed ID: 18705749
[TBL] [Abstract][Full Text] [Related]
5. Evidence for the involvement of the serotonergic 5-HT2A/C and 5-HT3 receptors in the antidepressant-like effect caused by oral administration of bis selenide in mice.
Jesse CR; Wilhelm EA; Bortolatto CF; Nogueira CW
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):294-302. PubMed ID: 19961893
[TBL] [Abstract][Full Text] [Related]
6. Antidepressant-like effect of 17beta-estradiol: involvement of dopaminergic, serotonergic, and (or) sigma-1 receptor systems.
Dhir A; Kulkarni SK
Can J Physiol Pharmacol; 2008 Oct; 86(10):726-35. PubMed ID: 18841177
[TBL] [Abstract][Full Text] [Related]
7. Antidepressant-like effect of the extract of Rosmarinus officinalis in mice: involvement of the monoaminergic system.
Machado DG; Bettio LE; Cunha MP; Capra JC; Dalmarco JB; Pizzolatti MG; Rodrigues AL
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):642-50. PubMed ID: 19286446
[TBL] [Abstract][Full Text] [Related]
8. Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor.
Dhir A; Kulkarni SK
Eur J Pharmacol; 2007 Jul; 568(1-3):177-85. PubMed ID: 17509558
[TBL] [Abstract][Full Text] [Related]
9. Antidepressant-like action of the ethanolic extract from Tabebuia avellanedae in mice: evidence for the involvement of the monoaminergic system.
Freitas AE; Budni J; Lobato KR; Binfaré RW; Machado DG; Jacinto J; Veronezi PO; Pizzolatti MG; Rodrigues AL
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):335-43. PubMed ID: 20026371
[TBL] [Abstract][Full Text] [Related]
10. Evidence for the involvement of the monoaminergic system in the antidepressant-like effect of magnesium.
Cardoso CC; Lobato KR; Binfaré RW; Ferreira PK; Rosa AO; Santos AR; Rodrigues AL
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):235-42. PubMed ID: 19059299
[TBL] [Abstract][Full Text] [Related]
11. Involvement of dopamine receptors in the antidepressant-like effect of melatonin in the tail suspension test.
Binfaré RW; Mantovani M; Budni J; Santos AR; Rodrigues AL
Eur J Pharmacol; 2010 Jul; 638(1-3):78-83. PubMed ID: 20406627
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of the selective 5-HT1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): in vivo neurochemical and behavioural evidence of anxiolytic/antidepressant activity.
Dawson LA; Hughes ZA; Starr KR; Storey JD; Bettelini L; Bacchi F; Arban R; Poffe A; Melotto S; Hagan JJ; Price GW
Neuropharmacology; 2006 Jun; 50(8):975-83. PubMed ID: 16581092
[TBL] [Abstract][Full Text] [Related]
13. Neural mechanisms underlying motor dysfunction as detected by the tail suspension test in MPTP-treated C57BL/6 mice.
Mori A; Ohashi S; Nakai M; Moriizumi T; Mitsumoto Y
Neurosci Res; 2005 Mar; 51(3):265-74. PubMed ID: 15710490
[TBL] [Abstract][Full Text] [Related]
14. Involvement of monoaminergic systems in the antidepressant-like effect of nobiletin.
Yi LT; Xu HL; Feng J; Zhan X; Zhou LP; Cui CC
Physiol Behav; 2011 Jan; 102(1):1-6. PubMed ID: 20951716
[TBL] [Abstract][Full Text] [Related]
15. Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors.
Brocco M; Dekeyne A; Papp M; Millan MJ
Behav Pharmacol; 2006 Nov; 17(7):559-72. PubMed ID: 17021388
[TBL] [Abstract][Full Text] [Related]
16. Sigma 1 receptor-mediated increase in hippocampal extracellular dopamine contributes to the mechanism of the anticonvulsant action of neuropeptide Y.
Meurs A; Clinckers R; Ebinger G; Michotte Y; Smolders I
Eur J Neurosci; 2007 Dec; 26(11):3079-92. PubMed ID: 18005069
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant-like effects of the glucocorticoid receptor antagonist RU-43044 are associated with changes in prefrontal dopamine in mouse models of depression.
Ago Y; Arikawa S; Yata M; Yano K; Abe M; Takuma K; Matsuda T
Neuropharmacology; 2008 Dec; 55(8):1355-63. PubMed ID: 18796307
[TBL] [Abstract][Full Text] [Related]
18. Antidepressant-like pharmacological profile of 3-(4-fluorophenylselenyl)-2,5-diphenylselenophene: Involvement of serotonergic system.
Gay BM; Prigol M; Stein AL; Nogueira CW
Neuropharmacology; 2010 Sep; 59(3):172-9. PubMed ID: 20488195
[TBL] [Abstract][Full Text] [Related]
19. Effect of various classes of antidepressants in behavioral paradigms of despair.
Kulkarni SK; Dhir A
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1248-54. PubMed ID: 17570574
[TBL] [Abstract][Full Text] [Related]
20. S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: III. Actions in models of potential antidepressive and anxiolytic activity in comparison with ropinirole.
Millan MJ; Brocco M; Papp M; Serres F; La Rochelle CD; Sharp T; Peglion JL; Dekeyne A
J Pharmacol Exp Ther; 2004 Jun; 309(3):936-50. PubMed ID: 14978196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
